Hepion Pharmaceuticals, Inc. (HEPA) Stock Forecast
HEPA analyst forecast
as of October 21, 2026- Analyst consensus
- Hold 3.00 / 5 from 1 analysts
- Price target
- $30.00 average of analyst targets
- Upside to target
- +25,388.5% from the latest close
- Next earnings
- —
- 52-week range
- $0.04 – $0.12
HEPA analyst ratings
1 analystsNumber of analysts at each rating.
HEPA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HEPA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; HEPA beat in 5 of 9.
What analysts expect from HEPA
1 analysts cover Hepion Pharmaceuticals; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $30.00, 25,388.5% above the latest close of $0.12. Hepion Pharmaceuticals beat the EPS estimate in 5 of the last 9 quarters.
Related: HEPA income statement, HEPA key metrics, HEPA chart. See the HEPA stock overview for the latest quote and news.
HEPA forecast FAQ
What is Hepion Pharmaceuticals's price target?
The average analyst price target for Hepion Pharmaceuticals is $30.00, 25,388.5% above the latest close of $0.12.
Is Hepion Pharmaceuticals a buy, hold or sell?
Of 1 analysts covering Hepion Pharmaceuticals, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
Does Hepion Pharmaceuticals usually beat earnings estimates?
Hepion Pharmaceuticals reported EPS at or above the analyst estimate in 5 of the last 9 quarters.